The efficacy of bolus doses of intravenous methylprednisolone (MPIV) in the treatment of acute renal allograft rejection.
D000284:Administration, Oral; D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004285:Dogs; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000188:drug therapy*; D006801:Humans; D007275:Injections, Intravenous; D016030:Kidney Transplantation; D008775:Methylprednisolone / Q000008:administration & dosage* / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D003520:Cyclophosphamide; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone